VIROCELL BIOLOGICS LTD
Executive Summary
ViroCell Biologics Ltd has quickly established itself as a specialist CDMO in the high-potential gene and cell therapy sector, supported by strong equity capital and significant fixed asset investments. The company’s growth hinges on scaling manufacturing capacity, leveraging strategic partnerships, and advancing proprietary technology, while addressing risks related to cash burn, regulatory compliance, and competitive pressures. Focused execution on operational scalability and market penetration will be crucial to transition from investment phase to sustainable profitability.
View Full Analysis Report →- Address
- 25 East 86th Street, Suite 3D, New York, 10028Copied!
Latest financial results as of 30 July 2025- Cash in bank
- £6.05m
- Current assets
- £6.55m
- Fixed assets
- £1.23m
- Current creditors
- £4.35m
- Shareholders funds
- £22.67m
View full financial accounts- Cash in bank
- £6.05m
- Current assets
- £6.55m
- Fixed assets
- £1.23m
- Current creditors
- £4.35m
- Shareholders funds
- £22.67m
- Company number
- 13033264 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 3 December 2024
Next statement due by 17 December 2025
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
- Legal registered address
- The Portland Building 27-28 Church Street Brighton East Sussex United Kingdom BN1 1RB Copied!
Latest company documents
| Date | Description |
|---|---|
| 28/07/2528 July 2025 New | Resolutions |
| 28/07/2528 July 2025 New | Memorandum and Articles of Association |
| 30/05/2530 May 2025 | Director's details changed for John Andrew Dawson on 2025-05-29 |
| 29/05/2529 May 2025 | Director's details changed for Cedriane Marie De Boucaud Truell on 2025-05-29 |
| 29/05/2529 May 2025 | Director's details changed for Todd C Davis on 2025-05-29 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company